AgeneBio, Inc., is an emerging pharmaceutical company dedicated to developing innovative therapeutics that prevent neurodegeneration and preserve and restore cognitive function for unserved patients battling amnestic mild cognitive impairment (aMCI), the symptomatic pre-dementia stage of Alzheimer’s...
Use this information to figure out if this company is an ideal customer for you.
410.685.3000
601 S Charles Street
Baltimore, 21209
11 - 50 Employees
$1M - $5M
linkedin.com/company/agenebio-inc-
The most common AgeneBio email format is [first].[last] (ex. john.doe@agenebio.com), currently being used by 99% of AgeneBio business email addresses. There are 4 email formats used by AgeneBio.
AgeneBio's CEO is Michela Gallagher
AgeneBio's HQ is located at 601 S Charles Street, Baltimore
AgeneBio's phone number is 410.685.3000
AgeneBio's official website is agenebio.com
AgeneBio's revenue is $1M - $5M
AgeneBio has 11 - 50 employees
AgeneBio is in the industry of: Pharmaceuticals
